734383

Novo Nordisk Pharmaceutical Industries LP — FEI 1000158576

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 1, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Clayton, NC (United States)